A Case of Multiple Primary Malignancies in One Patient
Author Information
Author(s): Fletcher Horace, Wharfe Gilian, Williams Elaine, Hanchard Barrie, Mitchell Derek
Primary Institution: University of the West Indies, Mona, Kingston, Jamaica
Hypothesis
What are the implications of long-term tamoxifen use on the development of multiple primary malignancies?
Conclusion
The long-term use of tamoxifen appears to be a significant risk factor for developing endometrial cancer in this patient.
Supporting Evidence
- Tamoxifen is known to increase the risk of endometrial cancer.
- The patient had a history of breast cancer and long-term tamoxifen use.
- Multiple myeloma was diagnosed as a separate malignancy.
- The patient developed endometrial adenocarcinoma after stopping tamoxifen.
Takeaway
This study talks about a woman who had three different cancers over seven years, and it suggests that the medicine she took for breast cancer might have caused another cancer.
Methodology
Case report detailing the patient's medical history and treatment.
Potential Biases
Potential bias in reporting due to the nature of a case report.
Limitations
The study is based on a single case, limiting generalizability.
Participant Demographics
61-year-old female, Para 4.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website